A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder

Clinical trial NCT02985749 · COMPLETED

Trial details

NCT number: NCT02985749
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Autism Spectrum Disorder Pervasive Developmental Disorder ASD PDD

Start date: 2017-10-09
Primary completion: 2019-01-09
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.